Literature DB >> 1306598

[Bone and visceral manifestations of lipoatrophic diabetes. Apropos of a case].

B de Wazieres1, D Wendling, T Fest, G Morin, J L Dupond.   

Abstract

Lipoatrophic diabetes, known by pediatricians as Lawrence-Seip disease or Berardinelli lipodystrophy syndrome, is an infrequent condition of which approximately one hundred cases have been published to date. A case in a 24-year-old female with a fifteen-year follow-up is reported. Manifestations included acanthosis nigricans, generalized lipoatrophy, hirsutism, muscle hypertrophy, and intellectual impairment. Biologic tests revealed insulin-resistant diabetes mellitus with major diet-dependent type V hypertriglyceridemia. The patient had nephrotic syndrome (focal and segmental endocapillary proliferative glomerulonephritis without dense deposits). Phosphorus and calcium determinations were normal, as were the endocrinologic tests. Roentgenograms of the bones disclosed increased density of axial bones and large epiphyseal defects with increased bone density as determined by osteodensitometric studies. The bone manifestations of this syndrome have been documented but are often overshadowed by the severe metabolic alterations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306598

Source DB:  PubMed          Journal:  Rev Rhum Mal Osteoartic        ISSN: 0035-2659


  3 in total

1.  Rheumatological manifestations of lipoatrophic diabetes.

Authors:  P C Coelho; A Jordao; O André; M V de Queiroz; P Eurico-Lisboa
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

2.  Case report: unicameral bone cysts in a young patient with acquired generalized lipodystrophy.

Authors:  James M Gregory; Alexandre Arkader; Aqiba Bokhari; Aqiba Bothari; John P Dormans
Journal:  Clin Orthop Relat Res       Date:  2009-11-19       Impact factor: 4.176

Review 3.  Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; Suresh C Tyagi; Lisa Kolb; James R Sowers; Ramesh Khanna
Journal:  Cardiovasc Diabetol       Date:  2005-03-18       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.